Key Segmentation:
By Type
-
Croscarmellose Sodium
-
Crospovidone
-
Sodium Starch Glycolate
-
Natural Superdisintegrants
-
Others
By Formulation
-
Tablets
-
Capsules
-
Orally Disintegrating Tablets
-
Others
By Therapeutic Area
-
Neurological Diseases
-
Gastrointestinal Diseases
-
Cardiovascular Diseases
-
Oncology
-
Others
By End User
-
Pharmaceutical Companies
-
Contract Manufacturing Organizations
-
Academic & Research Institutes
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
The Superdisintegrants Market is expected to grow at a CAGR of 7.64% from 2026 to 2035.
The Superdisintegrants Market was valued at USD 538.7 Million in 2025.
Expanding pharmaceutical solid dosage form pipeline creating formulation procurement, ODT adoption in paediatric and geriatric populations requiring faster mouth dissolution, growing biosimilar and generic tablet manufacturing, and natural superdisintegrant development aligned with pharmaceutical sustainability initiatives are the primary growth factors.
Croscarmellose Sodium dominated with the largest share in 2025.
North America dominated the Superdisintegrants Market in 2025 with approximately 40.25% of global revenues.